Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University, Leipziger St. 44, 39120 Magdeburg, Germany.
World J Gastroenterol. 2010 Jan 28;16(4):467-73. doi: 10.3748/wjg.v16.i4.467.
To study the impact of an endoscopy-based long-term study on the quality of life in healthy volunteers (HV).
Ten HV were included into a long-term prospective endoscopy-based placebo-controlled trial with 15 endoscopic examinations per person in 5 different drug phases. Participants completed short form-36 (SF-36) and visual analog scale-based questionnaires (VAS) for different abdominal symptoms at days 0, 7 and 14 of each drug phase. Analyses were performed according to short- and long-term changes and compared to the control group.
All HV completed the study with duration of more than 6 mo. Initial quality of life score was comparable to a general population. Analyses of the SF-36 questionnaires showed no significant changes in physical, mental and total scores, either in a short-term perspective due to different medications, or to potentially endoscopic procedure-associated long-term cumulative changes. Analogous to SF-36, VAS revealed no significant changes in total scores for pathological abdominal symptoms and remained unchanged over the time course and when compared to the control population.
This study demonstrates that quality of life in HV is not significantly affected by a long-term endoscopy-based study with multiple endoscopic procedures.
研究基于内镜的长期研究对健康志愿者(HV)生活质量的影响。
10 名 HV 纳入一项长期前瞻性内镜下安慰剂对照试验,每人在 5 个不同药物阶段进行 15 次内镜检查。参与者在每个药物阶段的第 0、7 和 14 天完成简短形式 36 项(SF-36)和基于视觉模拟量表的问卷(VAS),用于评估不同的腹部症状。根据短期和长期变化进行分析,并与对照组进行比较。
所有 HV 均完成了持续时间超过 6 个月的研究。初始生活质量评分与一般人群相当。SF-36 问卷分析显示,无论是由于不同药物引起的短期变化,还是潜在的内镜程序相关的长期累积变化,身体、心理和总分均无显著变化。类似地,VAS 显示病理性腹部症状的总评分无显著变化,并且在整个时间过程中保持不变,与对照组相比也没有变化。
本研究表明,HV 的生活质量不受多次内镜检查的长期内镜研究的显著影响。